Okabe H, Lehrer M, Karmen A
Tohoku J Exp Med. 1986 Mar;148(3):267-73. doi: 10.1620/tjem.148.267.
The effects of diphenylhydantoin and phenobarbital on lipids metabolism were studied by quantification of lipids in human serum with GC-MS. The ratios of palmitic acid to stearic, oleic and linoleic acids decreased in patients on diphenylhydantoin therapy. Increases of free palmitic, stearic and oleic acids concentrations as well as higher cholesterol ester levels were observed in patients receiving either diphenylhydantoin or phenobarbital. With respect to fatty acids composition of cholesterol esters and phosphatidyl-choline, higher concentrations of palmitic, oleic and linoleic acids were observed in patients on diphenylhydantoin and phenobarbital therapy. Although the concentration of palmitic acid in serum phosphatidylcholine remained the same for all groups, a marked decrease in stearic, oleic and linoleic acids concentrations in serum phosphatidylcholine was observed in diphenylhydantoin treated group, and oleic acid in phenobarbital treated group. These results suggested the relationship to lecithin-cholesterol acyltransferase activity by these drugs.
通过气相色谱-质谱联用技术对人血清中的脂质进行定量分析,研究了苯妥英钠和苯巴比妥对脂质代谢的影响。接受苯妥英钠治疗的患者中,棕榈酸与硬脂酸、油酸和亚油酸的比例降低。接受苯妥英钠或苯巴比妥治疗的患者中,游离棕榈酸、硬脂酸和油酸浓度升高,胆固醇酯水平也更高。就胆固醇酯和磷脂酰胆碱的脂肪酸组成而言,接受苯妥英钠和苯巴比妥治疗的患者中,棕榈酸、油酸和亚油酸的浓度更高。尽管所有组血清磷脂酰胆碱中棕榈酸的浓度保持不变,但在苯妥英钠治疗组的血清磷脂酰胆碱中,硬脂酸、油酸和亚油酸的浓度显著降低,在苯巴比妥治疗组中油酸浓度降低。这些结果表明这些药物与卵磷脂胆固醇酰基转移酶活性之间存在关联。